טוען...
Patient-tailored Drug-eluting Stent Choice – A Solution for Patients with Diabetes: Proceedings of Two Satellite Symposia Held at EuroPCR in May 2015 in Paris
Although second-generation drug-eluting stents (DES) have improved outcomes in percutaneous coronary interventions (PCIs), important unmet needs remain. Two symposia at EuroPCR 2015 focused on two challenging scenarios. First, patients with diabetes mellitus (DM) have generally inferior outcomes fol...
שמור ב:
| הוצא לאור ב: | Interv Cardiol |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Radcliffe Cardiology
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5808667/ https://ncbi.nlm.nih.gov/pubmed/29588695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/ICR.2015.10.03.158 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|